lixisenatide 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
peptides and glycopeptides 4815 320367-13-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • adlyxin
  • AVE-0010
  • lixisenatide
  • lyxumia
  • AVE0010
A synthetic GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist that binds GLP-1 receptor that is used to control blood sugar levels in patients with TYPE 2 DIABETES; amino acid sequence is H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSK KKKKK-NH2 (ZP10A).
  • Molecular weight: 4858.56
  • Formula: C215H347N61O65S
  • CLOGP:
  • LIPINSKI: None
  • HAC: 126
  • HDO: 70
  • TPSA: 2060.16
  • ALOGS:
  • ROTB: 169

Drug dosage:

DoseUnitRoute
40 U P
20 mcg P

ADMET properties:

None

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

lixisenatide